Evotec SE's stock has declined over 30% in a single day, marking a 5-year decline of over 56%. See why I think EVO stock is a ...

HAMBURG, GERMANY / ACCESSWIRE / April 23, 2024 / The Supervisory Board of (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: ...

Q4 2023 Earnings Call April 24, 2024 Evotec SE misses on earnings expectations. Reported EPS is $-0.05 EPS, expectations were ...

Adjusted Group EBITDA at €66.4M (2022: €101.7M), adjusted for one-off effects related to the recovery from the severe ...

HAMBURG, GERMANY / ACCESSWIRE / April 17, 2024 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) will announce its financial results for 2023 on Wednesday, 24 ...

Evotec SE ADR (NASDAQ: EVO)’s stock price has dropped by -31.26 in relation to previous closing price of 7.65. Nevertheless, the company has seen a loss of -27.36% in its stock price over the last ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer 23-Apr-2024 / 20:38 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, ...

Ladies and gentlemen, welcome to the Evotec SE Annual Report 2023 Conference Call. I’m Moritz Nikolaus, call operator. I would like to remind you that all participants will be in a listen-only ...

EQS-News: EVOTEC SE / Key word (s): Personnel Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer 23.04.2024 / 20:40 CET/CEST The issuer is solely responsible for the content of ...

Thank you. Volker Braun: Let’s try from a few angles, Peter. So, let’s start in the area of Just-Evotec Biologics. The last year I’ve seen is that we reached €850 million. I mean ...